Teva Investors Get Go-Ahead To Resume Kickbacks Class Suit
By Emilie Ruscoe · September 3, 2024, 10:57 PM EDT
A shareholder's certified class action against pharmaceutical company Teva can resume after being paused for two years, as the company says it is working towards a settlement with the U.S. Department of Justice...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login